NCOA4 is an important mediator of ferritinophagy, and WB analysis of NCOA4 indicated that ferritinophagy occurs in CKD and can be enhanced or down-regulated by CDDP or DFO treatment, respectively (Fig. 4a, g). This evidence concerns the gene NCOA4 and chronic kidney disease.